| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 07/04/2007 | EP1803462A2 Application of compounds containing petasites for treating diseased states |
| 07/04/2007 | EP1802250A1 Methods of treating wounds with gonyautoxins |
| 07/04/2007 | EP1311699B1 Adeno-associated virus-mediated delivery of angiogenic factors |
| 07/04/2007 | EP1286690B1 Use of alpha-msh and epo for the manufacture of a medicament for preventing or treating ischemic conditions |
| 07/04/2007 | CN1993463A Follistatin mutant polypeptide |
| 07/04/2007 | CN1989969A Cyclic protein tyrosine kinase inhibitors |
| 07/04/2007 | CN1324018C Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 07/04/2007 | CN1324008C Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2007 | CN1323716C Use of SAPR-1 for the treatment and/or prevention of scleroderma |
| 07/04/2007 | CN1323592C Method for preparing 'Kawa' soybean milk taken at night for soothing nerves |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238718 Method for treating myolytic disease and method for screening antimyolytic agent |
| 07/03/2007 | US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 07/03/2007 | US7238703 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
| 07/03/2007 | US7238487 Therapeutic agent for fibromyalgia |
| 06/28/2007 | WO2007073424A1 Pure rocuronium bromide |
| 06/28/2007 | WO2007072977A1 Pharmaceutical composition for allergic disease |
| 06/28/2007 | WO2007072645A1 Method of regulating cell size and/or cell cycle |
| 06/28/2007 | WO2007072503A2 Combinations for managing inflammation and associated disorders |
| 06/28/2007 | WO2007071839A2 Potentiation of apoptosis by monoclonal antibodies |
| 06/28/2007 | US20070149619 Anti-aging agent |
| 06/28/2007 | US20070149555 Prophylatic and/or therapeutic agents for chronic musculoskeletal pain |
| 06/28/2007 | US20070149455 Modified and stabilized gdf propeptides and uses thereof |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148189 Stable Liquid Formulations of Botulinum Toxin |
| 06/28/2007 | US20070148108 Stable vitamin b6 derivative |
| 06/28/2007 | CA2634824A1 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation |
| 06/28/2007 | CA2633331A1 Potentiation of apoptosis by monoclonal antibodies |
| 06/28/2007 | CA2618272A1 Pure rocuronium bromide |
| 06/27/2007 | EP1800673A2 Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction |
| 06/27/2007 | EP1799709A1 Myostatin isoform |
| 06/27/2007 | EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/27/2007 | EP1392259B1 Delivery of erectile dysfunction drugs through an inhalation route |
| 06/27/2007 | EP1368312B1 Benzo[f]isoindole derivatives with affinity to the ep4 receptor |
| 06/27/2007 | EP1366025B1 Agonists of beta-adrenoreceptors |
| 06/27/2007 | EP1355936B1 Polymer conjugates of neublastin and methods of using same |
| 06/27/2007 | CN1985849A Medicine preparation for treating severe myasthenia |
| 06/27/2007 | CN1985833A Use of estrone derivative EA204 in preparing vascular smooth muscle relaxant |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout |
| 06/26/2007 | US7235552 Cholenic acid amides and pharmaceutical compositions thereof |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7234469 Surface topography method for determining effect of a botulinum toxin upon a muscle |
| 06/21/2007 | WO2007069900A1 Use of soluble dietary fibres against muscle wasting |
| 06/21/2007 | WO2007068255A1 Use of effector-function-deficient antibodies for treatment of auto-immune diseases |
| 06/21/2007 | US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors |
| 06/21/2007 | US20070142470 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate |
| 06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
| 06/21/2007 | US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 06/21/2007 | US20070142291 Methods for treating irritable bowel syndrome |
| 06/21/2007 | CA2633292A1 Use of soluble dietary fibres against muscle wasting |
| 06/20/2007 | EP1797878A2 Benzothiazole derivatives |
| 06/20/2007 | EP1534256A4 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/20/2007 | EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 06/20/2007 | EP1324760B1 Creatine ester pronutrient compounds and formulations |
| 06/20/2007 | EP1272204B1 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 06/20/2007 | EP1159405B1 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
| 06/20/2007 | CN1981744A Production of injection slow-releasing micropills of lycopodine and its derivative |
| 06/19/2007 | US7232909 Pyridine derivatives |
| 06/19/2007 | US7232827 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives |
| 06/19/2007 | US7232580 Use of extracts of Ginkgo biloba for preparing a medicament intended to treat sarcopenia |
| 06/14/2007 | WO2007066305A1 Compositions comprising sesquiterpene compounds for use in the prophylaxis or treatment of pain |
| 06/14/2007 | WO2007065421A1 Treatment of trichodynia and superficial temporal artery swelling |
| 06/14/2007 | US20070135484 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 06/14/2007 | US20070135386 Novel Compounds and Compositions as Cathepsin Inhibitors |
| 06/14/2007 | US20070134258 Gasp1: a follistatin domain containing protein |
| 06/13/2007 | EP1416931B1 Inhibitors of polyq-aggregation |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1027429B1 Jnk3 modulators and methods of use |
| 06/13/2007 | CN1980642A Bioavailable metaxalone solid dosage forms |
| 06/13/2007 | CN1977837A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977836A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1320884C Muscle strong agent and anti-inflammatory agent |
| 06/13/2007 | CN1320880C Improved formulation for topical non-invasive application in vivo |
| 06/12/2007 | US7230132 Aryl N-cyanoguanidines and methods related thereto |
| 06/12/2007 | US7230026 Selected fused pyrrolocarbazoles |
| 06/12/2007 | US7230019 As neuroprotective agents in the therapy of neuronal disorders of the central and peripheral nervous systems |
| 06/12/2007 | US7230011 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5ht6 receptor |
| 06/12/2007 | US7229993 Aryl substituted pyrimidines and the use thereof |
| 06/12/2007 | US7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 06/07/2007 | WO2007065167A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 06/07/2007 | WO2007063946A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 06/07/2007 | WO2007020103A3 Novel use of peptide compounds for treating muscle pain |
| 06/07/2007 | US20070129348 Receptor antagonist |
| 06/07/2007 | US20070129316 antidepressant comprising at least one of scymnol or scymnol esters, soybean isoflavones and soybean isoflavone glycosides, curcumin, and or cholic acid; herbal medicine |
| 06/07/2007 | US20070129315 3-O- beta -D-xylopyranosyl-3-O-demethylthiocolchicine or 3-O- beta -L-xylopyranosyl-3-O-demethylthiocolchicine; gout , antiinflammation; muscle relaxant |
| 06/07/2007 | US20070129285 Protein a compositions and methods of use |
| 06/07/2007 | US20070128648 Methods for the Identification of IKKalpha Function and other Genes Useful for Treatment of Inflammatory Diseases |
| 06/07/2007 | US20070128227 Multi-step therapy for injured muscles |
| 06/07/2007 | US20070128203 Anti-integrin antibodies, compositions, methods and uses |
| 06/07/2007 | US20070128163 Adeno-associated virus-mediated delivery of angiogenic factors |
| 06/07/2007 | CA2631760A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 06/06/2007 | EP1791552A2 Protein a compositions and methods of use |
| 06/06/2007 | EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 06/06/2007 | EP1406637B1 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative |
| 06/06/2007 | EP0954317B1 Use of 7 apha-substituted steroids to treat neuropsychiatric disorders |
| 06/06/2007 | CN1973851A Application of astragalus root and astragalus polysaccharide in preparing medicine for treating neurodegenerative diseases |
| 06/06/2007 | CN1319982C Sheep growth hormone releasing hormone gene and its expression product and application |
| 06/06/2007 | CN1319974C Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| 06/06/2007 | CN1319530C Neurotrophic factor production promoter |